Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

Strides Arcolab arm receives US FDA nod for Chemotherapy Drug

Posted On: 2012-08-07 23:16:29

Strides Arcolab's subsidiary Onco Therapies Limited has received final ANDA approval for Oxaliplatin Injection 50mg/10mL and 100mg/20mL.

The company had receive tentative approval from USFDA in November 2011 based on a Para III filing. This approval was later converted to a Para IV filing based on which USFDA has now granted final approval.

According to IMS data, the US market for generic Oxaliplatin is approximately $1.5 billion.

Oxaliplatin is part of the oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch.

Oxaliplatin is a chemotherapy drug used to treat advanced cancer of the colon and rectum. It is used in combination with other medications to slow or stop cancer cell growth.

The Strides Arcolab Ltd. stock was trading at Rs.754.45, up by Rs.30.05 or 4.15%. The stock hit an intraday high of Rs.760.05 and low of Rs.729.

The total traded quantity was 0.49 lakhs compared to 2 week average of 0.40 lakhs.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Radico Khaitan Ltd Q2 net profit soars to Rs. 28.60 crores
Mahindra Lifespace Developers Ltd updates on JV with HDFC Fund
Borosil Glass Works Ltd calls for Board Meeting on Nov 2, 2017
Music Broadcast Ltd to consider 2nd quarter results on Nov 1, 2017
Inox Leisure Ltd to announce Q2 results on Oct 31, 2017
SRM Energy Ltd announces resignation of Mr. Sameer Rajpal
Infosys Ltd Board declares Interim Dividend of Rs. 13 for 2017-18
KSE Ltd to consider quarterly results on Nov 14, 2017
Rural Electrification Corporation Ltd calls for Board Meeting on Nov 6, 2017
Asian Paints Ltd Board declares Interim Dividend of Rs. 2.65
Camlin Fine Sciences Ltd to consider second quarter results on Nov 1, 2017
Coffee Day Enterprises Ltd calls for Board Meeting on Nov 9, 2017
IL&FS Transportation Networks Ltd to approve second quarter results on Nov 10, 2017
National Fertilizers to consider Q2 results on Nov 10, 2017
SAIL to consider 2nd quarter results on Nov 9, 2017
Bajaj Hindusthan Sugar Limited calls for Board Meeting on Oct 27, 2017
NLC India Ltd calls for Board Meeting on 7th November,2017
Dalmia Bharat Ltd to consider Q2 results on Nov 7, 2017
Cindrella Hotels Ltd updates on sale of property
Zee Entertainment Enterprises Ltd Q2 net profit jumps to Rs. 590.80 crores
Reliance Nippon Life Insurance Company renewal premium grew to Rs. 762 crore
Tara Jewels Ltd receives export orders of Rs. 83.2 crores
TTK Prestige Ltd posts net profit of Rs. 43.28 crores in Q2
HDFC Bank Ltd Q2 PAT rises to Rs. 4151.03 crores
Phillips Carbon Black Ltd Q2 net profit higher at Rs. 50.78 crores
Bharat Road Network Ltd to announce second quarter results on Nov 2, 2017
Wheels India Ltd to consider Q2 results on Nov 6, 2017
Hikal Ltd calls for Board Meeting on Nov 1, 2017
Surat Textile Mills Ltd calls for Board Meeting on Oct 30, 2017
InterGlobe Aviation Ltd calls for Board Meeting On Oct 31 2017
Balrampur Chini Mills Ltd to approve Q2 results on Nov 7, 2017
Phillips Carbon Black Ltd Board declares Interim Dividend of Rs. 6 for FY17-18
Ras Resorts & Apart Hotels Ltd calls for Board Meeting on Nov 11, 2017
Greenply Industries to consider Q2 results on Nov 8, 2017
Punjab Communications Ltd calls for Board Meeting on Nov 14, 2017
TI Financial Holdings Ltd to consider 2nd quarter results on Nov 11, 2017
Union Bank of India approves OTS proposal of Indosolar Ltd
India Cements Capital Ltd calls for Board Meeting on Nov 9, 2017
US FDA approves Panacea Biotec's ANDA of Prasugrel
PTC India Financial Services Ltd announces expiry of term of Director
Sintex Plastics Technology Ltd to consider 2nd quarter results on Oct 31, 2017
Vascon Engineers Limited receives Letter of Intent amounting to Rs. 70.40 Crores
Shree Cement Ltd calls for Board Meeting on Nov 8, 2017
Tata Steel Ltd to announce Q2 results on Oct 30, 2017
Tata Investment Corporation Ltd calls for Board Meeting on Nov 7, 2017
Johnson Controls-Hitachi Air Conditioning India Ltd calls for Board Meeting on Nov 7, 2017
Gabriel India Ltd announces resignation of Independent Director
Mangalam Cement Ltd to announce Q2 results on Nov 11, 2017
MM Forgings Ltd calls for Board Meeting on Nov 13, 2017
High Energy Batteries India Ltd to consider 2nd quarter results on Nov 11, 2017


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017